Trial Profile
Study of Two Regimens of TicagrElor Compared to Clopidogrel in Patients Undergoing ELective Percutaneous Coronary Intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms STEEL PCI
- 21 Jan 2019 Status changed from active, no longer recruiting to completed.
- 12 Jun 2018 Results published in the Circulation
- 18 Dec 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.